With over 1.89 million HIVE Blockchain Technologies Ltd. (HIVE) shares trading Monday and a closing price of $2.71 on the day, the dollar volume was approximately $5.11 million. The shares have shown a negative half year performance of -46.97% and its price on 03/13/23 gained nearly 15.32%. Currently, there are 116.94M common shares owned by the public and among those 83.39M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 3 analysts who have offered their price forecasts for HIVE have a consensus price objective of $5.33. The analysts have set the share’s price value over the next 12 months at a high of $7.00 and a low of $4.00. But an upside of 61.29% will see the stock hit the forecast high price target while median target price for the stock is $5.00.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Insiders at the company have transacted a total of 33 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 11 of these insider trades were purchases, accounting for 205,066 shares. Insider sales of the common stock occurred on 22 occasions, with total insider shares sold totaling 5,096,166 shares.
The top 3 mutual fund holders in HIVE Blockchain Technologies Ltd. are Amplify Transformational Data Sha, Invesco Mkts. II Plc – CoinShares, and Bitwise Crypto Industry Innovator. Amplify Transformational Data Sha owns 3.9 million shares of the company’s stock, all valued at over $11.11 million. Bitwise Crypto Industry Innovator now owns shares totaling to 1.12% of the shares outstanding.
Shares of HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) opened at $2.49, up $0.14 from a prior closing price of $2.35. However, the script later moved the day high at 2.7150, up 15.32%. The company’s stock has a 5-day price change of -2.52% and 41.88% over the past three months. HIVE shares are trading 88.19% year to date (YTD), with the 12-month market performance down to -70.54% lower. It has a 12-month low price of $1.36 and touched a high of $11.70 over the same period. HIVE has an average intraday trading volume of 1.27 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.05%, -5.30%, and -20.43% respectively.
Institutional ownership of HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) shares accounts for 16.33% of the company’s 116.94M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $316.91M and a beta (3y monthly) value of 4.37. The earnings-per-share (ttm) stands at -$4.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.31% over the week and 8.61% over the month.
Analysts forecast that HIVE Blockchain Technologies Ltd. (HIVE) will achieve an EPS of $0.02 for the current quarter, $0 for the next quarter and -$1.01 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.19 while analysts give the company a high EPS estimate of $0.23. Earnings per share for the fiscal year are expected to increase by 185.00%, and 94.00% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 3 brokerage firm advisors rate HIVE Blockchain Technologies Ltd. (HIVE) as a “Strong Buy” at a consensus score of 1.70. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 0 of the 3 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the HIVE, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on January 31, 2023, with the firm’s price target at $5. Stifel coverage for the HIVE Blockchain Technologies Ltd. (HIVE) stock in a research note released on March 25, 2022 offered a Buy rating with a price target of $3.75.
Leave a Reply